| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Cue Health Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.14 |
| 52 Week High | US$1.02 |
| 52 Week Low | US$0.13 |
| Beta | 1.22 |
| 1 Month Change | -24.48% |
| 3 Month Change | -37.33% |
| 1 Year Change | -84.16% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -99.30% |
Recent News & Updates
Recent updates
Investors Don't See Light At End Of Cue Health Inc.'s (NASDAQ:HLTH) Tunnel And Push Stock Down 26%
Mar 22
Cue Health Inc.'s (NASDAQ:HLTH) Price Is Right But Growth Is Lacking After Shares Rocket 31%
Jan 28We're A Little Worried About Cue Health's (NASDAQ:HLTH) Cash Burn Rate
Jan 06Investors Don't See Light At End Of Cue Health Inc.'s (NASDAQ:HLTH) Tunnel And Push Stock Down 28%
Nov 10These Analysts Think Cue Health Inc.'s (NASDAQ:HLTH) Sales Are Under Threat
Aug 14Can Cue Health (NASDAQ:HLTH) Afford To Invest In Growth?
Jul 12Revenue Downgrade: Here's What Analysts Forecast For Cue Health Inc. (NASDAQ:HLTH)
May 15Cue Health Inc. (NASDAQ:HLTH) Analysts Just Slashed This Year's Revenue Estimates By 56%
Mar 21We Think Cue Health (NASDAQ:HLTH) Needs To Drive Business Growth Carefully
Mar 12Cue Health Inc.'s (NASDAQ:HLTH) Intrinsic Value Is Potentially 44% Above Its Share Price
Feb 13Cue Health Inc. (NASDAQ:HLTH) Analysts Just Trimmed Their Revenue Forecasts By 24%
Nov 18Here's Why We're Not Too Worried About Cue Health's (NASDAQ:HLTH) Cash Burn Situation
Oct 30Cue Health applies for FDA emergency use nod for its flu & COVID-19 molecular test
Oct 04Cue Health appoints chief medical oficer
Sep 08Cue Health COVID-19 at-home, test-to-treat service launches nationwide
Aug 29Cue Health Non-GAAP EPS of -$0.37 beats by $0.09, revenue of $87.7M beats by $34.8M
Aug 10Cue Health's (NASDAQ:HLTH) Solid Profits Have Weak Fundamentals
May 18Shareholder Returns
| HLTH | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -3.0% | -2.9% | -3.2% |
| 1Y | -84.2% | -3.7% | 19.3% |
Return vs Industry: HLTH underperformed the US Medical Equipment industry which returned -3.7% over the past year.
Return vs Market: HLTH underperformed the US Market which returned 19.3% over the past year.
Price Volatility
| HLTH volatility | |
|---|---|
| HLTH Average Weekly Movement | 13.4% |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: HLTH's share price has been volatile over the past 3 months.
Volatility Over Time: HLTH's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 726 | Clint Sever | www.cuehealth.com |
Cue Health Inc. operates as a healthcare technology company. It provides the Cue Health platform that offers individuals and healthcare providers convenient and personalized access to lab-quality diagnostic tests at home and at the point-of-care, as well as on-demand telehealth consultations and treatment options for a range of health and wellness needs. It offers Cue Integrated Care platform comprising hardware, software, and diagnostic components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, including integration with electronic medical record system, pharmacies and last-mile delivery, clinician networks, and laboratories.
Cue Health Inc. Fundamentals Summary
| HLTH fundamental statistics | |
|---|---|
| Market cap | US$22.35m |
| Earnings (TTM) | -US$373.46m |
| Revenue (TTM) | US$70.94m |
0.3x
P/S Ratio-0.1x
P/E RatioIs HLTH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HLTH income statement (TTM) | |
|---|---|
| Revenue | US$70.94m |
| Cost of Revenue | US$265.71m |
| Gross Profit | -US$194.77m |
| Other Expenses | US$178.69m |
| Earnings | -US$373.46m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.36 |
| Gross Margin | -274.58% |
| Net Profit Margin | -526.48% |
| Debt/Equity Ratio | 0% |
How did HLTH perform over the long term?
See historical performance and comparison